skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/25/2006
Application #:
10131510
Filing Dt:
04/23/2002
Publication #:
Pub Dt:
09/04/2003
Inventor:
John S. Lollar
Title:
NUCLEIC ACID MOLECULES ENCODING MODIFIED FACTOR VIII PROTEINS, EXPRESSION PRODUCTS, AND METHODS OF MAKING THE SAME
Assignment: 1
Reel/Frame:
013378/0909Recorded: 01/23/2003Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/24/1999
Assignee:
2009 RIDGEWOOD DRIVE
ATLANTA, GEORGIA 30322
Correspondent:
GREENLEE, WINNER & SULLIVAN, P.C.
HEEJA YOO-WARREN
5370 MANHATTAN CIRCLE, STE. 201
BOULDER, CO 80303
Assignment: 2
Reel/Frame:
012836/0377Recorded: 04/23/2002Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
04/18/2002
Exec Dt:
04/18/2002
Exec Dt:
04/18/2002
Exec Dt:
04/18/2002
Exec Dt:
04/18/2002
Exec Dt:
04/18/2002
Assignee:
ONE NEUMANN WAY
CINCINNATI, OHIO 45215
Correspondent:
GREGORY GARMONG
PO BOX 12460
ZEPHYR COVE, NV 89448
Assignment: 3
Reel/Frame:
021251/0872Recorded: 07/17/2008Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/26/2006
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/07/2024 11:39 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT